1. Introduction {#sec1}
===============

*Trichosporon* species are emerging opportunistic basidiomycetous yeasts \[[@bib1]\]. The taxonomy of the genus *Trichosporon* is progressing fast with increased number of species causing disseminated trichosporonosis \[[@bib2]\]. *T. loubieri* is a rare species which has been reported recently as a cause of disseminated trichosporonosis, which is associated with high mortality regardless of antifungal therapy \[[@bib3], [@bib4], [@bib5]\]. Since *Trichosporon* species have different antifungal susceptibilities, it is important to speciate them accurately for specific therapy \[[@bib6]\]. Identification based solely on carbon and nitrogen assimilation profiles may not be totally reliable \[[@bib2]\]. Molecular methods like *Trichosporon asahii* specific Polymerase Chain Reaction (PCR) could identify only *T. asahii* isolates. Hence, sequencing of DNA fragments appeared to be a better approach for identification of *Trichosporon* species other than *T. asahii*. However, Internal Transcribed Spacer (ITS) sequencing was unable to differentiate several closely related species of the genus *Trichosporon* and Intergenic Spacer (IGS1) sequences unambiguously identified all *Trichosporon* isolates \[[@bib7]\]. Therefore, DNA amplification of the IGS region and nucleotide sequencing can be used in the identification of uncommon *Trichosporon* species like *T. loubieri*. To the best of our knowledge, very few cases of human trichosporonosis caused by *T. loubieri* have been reported worldwide so far. We herewith report two cases of complicated urinary tract infection due to *T. loubieri.*

2. Case {#sec2}
=======

2.1. Case I {#sec2.1}
-----------

The first patient was a 65-year old male who came to the urology department with complaint of left loin pain that was radiating to the back for the past two months. The patient also had decreased urine output and increased frequency of micturition for the past two months. On examination, the left testes was hard in consistency with grade III enlargement of the prostate which was non-tender but firm in consistency. Urine culture sent on day 0 had growth of *Escherichia coli* of \>100,000 cfu/ml. The serum creatinine level was 1.4mg/dL. Ultrasonogram (USG) of the abdomen showed left Hydroureteronephrosis of around 9.8 mm calculi in the upper ureter and prostate of 32cc with no intravesicular extension. Computed tomography of kidneys, ureters and bladder (CT KUB) also revealed left pelviureteric junction calculi of 1.4cm (1230 Hu) and vesical calculi of 5mm (800 Hu) (day +1). On day +2, the patient underwent Trans Ureteral Resection of Prostate (TURP) along with Cystolitholapaxy and left Double J stenting. The patient was treated with Tablet Finasteride 5mg, Tablet Magnesium & Potassium Citrate, Tab Tramadol and Tab Cefopodoxime 200mg + Clavulanate Potassium 125mg, and was discharged (day +3). After a week (day +10), the patient came with complaints of severe left loin pain. Left percutaneous nephrolithotomy was done for calculi in left pelvi ureteric junction and was discharged with nephrostomy tube in situ (day +13). After a week (day +20), the patient came to the urology OPD for follow up with complaints of haematuria and burning micturition. Urine culture sensitivity done on day +20, showed growth of dry yeast like colonies of ≥100,000 cfu/ml with no bacterial growth. The culture isolate showed blastoconidia, pseudohyphae, arthroconidia on gram stain and was also urease positive, and hence was considered as belonging to the genus *Trichosporon*. Identification of the culture till species level was done using IGS1 PCR and sequencing. The culture isolate was finally identified as *Trichosporon loubieri*. The MIC values by broth microdilution method for amphotericin B was 4 μg/ml, fluconazole 2 μg/ml, itraconazole 2 μg/ml, voriconazole 0.125 μg/ml, posaconazole 0.25 μg/ml, ravuconazole ≤0.125 μg/ml and caspofungin 8 μg/ml. The patient was started on fluconazole 200mg/day for 2 weeks and the nephrostomy tube was changed (day 21). The patient got well and discharged. The nephrostomy tube was removed on day +28.

2.2. Case II {#sec2.2}
------------

The next patient was one month old male infant who was brought to the Urology OPD with complaints of oliguria and fever for three days. The baby was born with birth weight of 2.9 kg by Lower Segment Caesarean Section (LSCS) with mild respiratory distress, after which the baby was fine with the resuscitative measures and was discharged. The laboratory values (day 0) were: Haemoglobin-10.9 g/dl, Total leucocyte count- 11000/mm3 (Neutrophil-52%, Lymphocyte-4%, Monocyte-1%, Eosinophil-0.3%), Mean Corpuscular Volume (MCV)- 60μm3, Serum Creatinine- 1.3mg/dl, Serum Urea 30 mg/dl, Urine analysis: specific gravity-1.005, protein ++, Gram stain of urine: plenty of pus cells, gram negative bacilli, and few budding yeast cells. Urine culture had growth of *Escherichia coli* with a colony count of \>100,000 cfu/ml. USG abdomen showed bilateral hydronephrosis with thickened bladder wall. Voiding cystourethrogram showed posterior ureteric valves (PUV) with right sided vesicoureteric reflex grade IV (day +1). Urinary catheter was placed to improve the draining of kidney (day +1). The patient was treated with cefoperazone sulbactam 40 mg and amikacin 30mg two times a day for 5 days (day +1). The patient continued to have fever. Second urine sample was collected and sent for culture (day +5). Direct microscopic examination of urine showed plenty of pus cells, moderate budding yeast cells and few gram negative bacilli. The urine culture showed growth of dry yeast like colonies (100000 cfu/ml) with no bacterial growth. Gram stain from the culture grown on Sabouraud dextrose Agar (SDA) showed budding yeast cells, pseudohyphae and arthroconidia. The culture isolate grew after 48 hrs, and was finally identified using IGS1 sequencing as *Trichosporon loubieri.* Antifungal susceptibility testing by broth microdilution method showed MIC values for amphotericin B 4 μg/ml, fluconazole 4 μg/ml, itraconazole 2 μg/ml, voriconazole ≤0.125 μg/ml, posaconazole 0.25 μg/ml, ravuconazole ≤0.125 μg/ml and caspofungin 8 μg/ml. The infant was started with voriconazole 20mg two times daily for five days. He was afebrile. Endoscopic valve ablation was performed after one week and renal function normalized. The infant was discharged home in good condition.

Both the isolates produced showing dry, white colonies with irregular foldings and central umbonation on SDA ([Fig. 1](#fig1){ref-type="fig"}). Gram stain from the colonies showed blastoconidia, pseudohyphae, arthroconidia and typical fusiform giant cells ([Fig. 2](#fig2){ref-type="fig"}) characteristic of *T. loubieri* as mentioned by *Gueho* et al. \[[@bib8]\]. The enzyme urease was produced in Christensen\'s urease medium, which is a characteristic feature of this genus. Hence, both the isolates were provisionally identified as belonging to the genus *Trichosporon*. Conventional phenotypic methods like sugar assimilation studies misidentified both these isolates as *T. asahii*. PCR was performed initially with *Trichosporon* genus specific primers \[[@bib9]\] (TRF (forward) -5′AGAGGCTACCATGGTATCA 3′ TRR (reverse) - 5′TAAGACCCAATAGAGCCCTA 3′) to double check for accurate identification of this genus. This primer pair is *Trichosporon* specific and it amplified part of 18S rDNA. Both the test isolates and positive controls (*T. asahii* MTCC 6179, *T. asteroides* MTCC 7632, *T. cutaneum* var. *cutaneum* MTCC 1963) produced bands of approximately 170 bp size ([Fig. 3](#fig3){ref-type="fig"}). There was no amplification in the negative control (*Candida albicans* ATCC 90028). Later, *T. asahii* specific PCR was performed using *T. asahii* specific primers (TASF - 5′GGATCATTAGTGATTGCCTTTATA3′ TASR -5′AGCACGCTTCAACACAATGGAC3′) \[[@bib10]\]. Both the isolates did not produce an amplicon, revealing the phenotypic misidentification of these isolates. Hence, these isolates were taken up for further speciation by IGS1 sequencing (Agrigenom, Kerala). PCR and sequencing was done using the 26F (5′-ATCCTTTGCAGACGACTTGA-3′) and 5SR (5′-AGCTTGACTTCGCAGATCGG-3′) primers \[[@bib7]\]. All the PCRs were performed with reaction conditions standardized in our laboratory as shown in [Table 1](#tbl1){ref-type="table"}. Phylogenetic analysis was done by comparing the obtained nucleotide sequences with the nucleotide sequences of *Trichosporon* reference strains obtained from the GenBank database (<http://www.ncbi.nih.gov/GenBank/>). The reference strains used are given in [Table 2](#tbl2){ref-type="table"}. All the phylogenetic analysis was done using MEGA Software, version 7.0. All the sequences were aligned and phylogenetic tree was constructed using Maximum parsimony clustering. Its stability was assessed by parsimony bootstrapping with 1000 pseudoreplications. To root the phylogenetic tree for all the *Trichosporon* isolates, the IGS1 sequences of *Cryptococcus neoformans* strain CBS 131 and *Cryptococcus gatti* strain CBS 6956, were used as outgroups. Both the isolates had identical sequence and clustered together with *T. loubieri* with high genetic relatedness (bootstrap ≥99). Hence, both these isolates were identified as *T. loubieri.* The length of the obtained sequence was 536bp for both the isolates and were deposited in GenBank database (Accession Nos. MG 912612 and MG 912613). Antifungal susceptibility testing was also performed for these isolates by broth microdilution method according to the CLSI M27- A3 document entitled 'Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard -- Third Edition**'**, intended for testing yeasts that cause invasive infections \[[@bib11]\] (CLSI Order \# 56600, id \# 476755).Fig. 1Colony morphology on SDA with antibiotics showing dry, white colonies with irregular foldings and central umbonation.Fig. 1Fig. 2Microscopic morphology of *T. loubieri* on gram stain showing hyphae with arthroconidia and typical fusiform giant cells (100× magnification).Fig. 2Fig. 3*Trichosporon* specific PCR.Fig. 3Table 1PCR reaction conditions.Table 1REACTION*Trichosporon* Specific*T. asahii* SpecificIGS1TempTimeTempTimeTempTimeInitial Denaturation95 °C7 Min95 °C7 Min95 °C7 MinDenaturation95 °C30 Sec95 °C30 Sec95 °C30 SecAnnealing54 °C30 Sec56 °C30 Sec56 °C30 SecExtension72 °C30 Sec72 °C30 Sec72 °C30 SecFinal Extension72 °C10 Min72 °C10 Min72 °C10 MinTable 2Reference strains used for phylogenetic analysis.Table 2Reference strainGenBank accession number*Trichosporon asahii*[KR872659.1](ncbi-n:KR872659.1){#intref0015}, [KR265116.1](ncbi-n:KR265116.1){#intref0020}*Trichosporon asteroides*EU93801.1, [KT240122.1](ncbi-n:KT240122.1){#intref0025}*Trichosporon fecale*[KM488293.1](ncbi-n:KM488293.1){#intref0030}, [KM488280.1](ncbi-n:KM488280.1){#intref0035}*Trichosporon inkin*[EU934804.1](ncbi-n:EU934804.1){#intref0040}*Trichosporon ovoides*[EU934805.1](ncbi-n:EU934805.1){#intref0045}, [AB066434.1](ncbi-n:AB066434.1){#intref0050}*Trichosporon loubieri*[AB066428.1](ncbi-n:AB066428.1){#intref0055}, [KT936593.1](ncbi-n:KT936593.1){#intref0060}*Trichosporon mucoides*[KP453832.1](ncbi-n:KP453832.1){#intref0065}, [KM821100.1](ncbi-n:KM821100.1){#intref0070}*Trichosporon cutaneum*[AB066415.1](ncbi-n:AB066415.1){#intref0075}*Cryprococcus neoformans*[AJ300916.1](ncbi-n:AJ300916.1){#intref0080}*Cryptococcus gattii*[AJ300920.1](ncbi-n:AJ300920.1){#intref0085}

3. Discussion {#sec3}
=============

*Trichosporon* sp. has been so far reported as the second most common cause of disseminated yeast infections in humans, next to the genus *Candida*. They are emerging opportunistic pathogens causing disseminated infections in immunocompromised patients \[[@bib1]\]. Also the taxonomy of this genus is expanding since 1992, due to molecular techniques. *T. asahii*, *T. mucoides*, and *T. asteroides* being the most common species causing human invasive disease, recently invasive infections with new *Trichosporon* spp. are frequently reported. Such infections are usually difficult to diagnose, do not respond to treatment with regularly used antifungal agents, and are associated with high mortality rates \[[@bib1]\].

Among the two cases of complicated urinary tract infection by *Trichosporon loubieri*, the first patient had Nephrostomy Tube Related Infection (NTRI). After a week of the procedure (Left PCNL), the patient developed fever, burning micturition and left flank pain with *T. loubieri* grown in urine culture of ≥100,000 cfu/ml**,** which is consistent with infection of the nephrostomy tube \[[@bib12]\]. Since *Trichosporon* species may constitute a part of normal flora of human skin and perigenital area, it is possible that this fungus colonised the catheter from the skin flora during catheterisation and also probably progressed into invasive trichosporonosis. Percutaneous nephrostomy tubes (PCN) are indicated for relief of urinary tract obstruction. These devices are prone to mechanical and infectious complications \[[@bib12]\]. Also, the patient had previous history of urinary tract infection with *Escherichia coli* and was treated for the same. Prior history of Urinary Tract Infection (UTI) was also found to be a significant risk factor for development of NTRI \[[@bib13]\]. This patient was started with fluconazole and nephrostomy tube was changed. The patient\'s clinical condition improved and got discharged. NRTIs begins with the colonisation of the external and/or luminal surfaces of these catheters by microbial biofilms. This may possibly progress to clinical infection, which can be associated with infective complications like pyelonephritis and this has the potential to evolve as urosepsis at a later stage \[[@bib14]\]. There are no antimicrobial nephrostomy catheters available with the potential to provide prophylaxis for catheter colonisation in nephrostomy patients. Hence, even when complications are absent, prophylactic change of PCN catheters has to be habitually performed in order to prevent nephrostomy tube related infections \[[@bib15]\]. Change of nephrostomy tube was the mainstay in the treatment of this patient which helped in the improvement of symptoms.

The second patient was a 1-month old male infant, a case of Bladder Outlet Obstruction due to Posterior urethral valves (PUV) with complicated UTI. The infant had UTI with *Escherichia coli* initially, and was treated for the same. After catheterisation, he had *T. loubieri* grown in urine culture. In this case, catheterisation could have played a major role as a risk factor, which abetted in the colonisation and later establishment of this yeast infection. PUV is a common cause of lower urinary tract obstruction in male infants. These infants are susceptible to UTIs due to poor drainage and elevated post-voidal residual urine volumes, leading to stasis of urine. Any infection that involves the kidney can cause secondary damage, resulting in greater impact on already impaired renal function which can progress to renal failure. Hence, prevention, early recognition and treatment of UTIs are critically important to protect existing kidney function and reducing further kidney damage from infection \[[@bib16]\]. In this case, the genus level of identification was done as soon as the yeast grew in culture and the patient was started with early treatment on voriconazole. Since *Trichosporon* species do not respond to the routinely used antifungal agents to treat yeast infections, timely identification helped in prompt treatment of this patient.

Both the patients were catheterised and grew *Trichosporon loubieri* in urine culture. This is a novel species which rarely causes human infections, though few cases of human trichosporonosis have been reported \[[@bib3], [@bib4], [@bib5],[@bib17],[@bib18]\]. Among these reported cases, three patients who had fungemia due to *T. loubieri*, succumbed to infection. The prognosis was good in other two patients who had left kidney infection \[[@bib17]\] and skin and soft tissue infection without fungemia \[[@bib18]\]. Similarly in these two cases blood cultures were negative for both the patients, they responded well to treatment and got discharged. This can also be attributed to early identification and rapid treatment of these patients which resulted in good clinical outcome.

*T. loubieri* which is a rare and new species causing human infection could not be identified by conventional phenotypic methods, and was misidentified as *T. asahii* in both cases. Yeast identification which is usually done based on physiological and biochemical tests may be laborious, leading to inconclusive presumptive identifications, mainly for uncommon or emerging fungi \[[@bib19]\]. Whereas, molecular techniques for the identification of yeasts are fully discriminative even for closely related species with high sensitivity and specificity \[[@bib20]\]. Recently, sequence analysis of the rRNA IGS1 region, which is a more powerful tool for distinguishing between phylogenetically closely related species, is used for identification of *Trichosporon* spp. \[[@bib7]\]. *T. loubieri* isolates in these two cases were unambiguously identified by IGS1 sequencing.

Both of the *T. loubieri* isolates had high MICs to amphotericin B (4 & 4 μg/ml) and caspofungin (8 μg/ml). *Trichosporon* infections when treated with these antifungal agents, may result in poor clinical outcome because of their high MICs. Hence, correct identification of the *Trichosporon* species using molecular methods with their antifungal susceptibility pattern, helps the clinician in providing appropriate treatment.

In conclusion, our cases highlight the need of molecular sequencing studies to identify *Trichosporon* to the species level. It also throws light on the fact that trichosporonosis can also be caused by rarer and emerging *Trichosporon* sp. like *T. loubieri*. These infections, if not identified accurately and treated promptly, may lead to dissemination with high mortality rates. Hence physicians and the laboratory personnel must be aware of the potential role of this species in causing human infections.
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